Wockhardt shares tumbled 8.16% to Rs 1,976.35 on Tuesday as investors booked profits following a sharp rally triggered by the recent U.S. FDA approval of its novel antibiotic, ZAYNICH.
Market Samachar is a news aggregator. This article was originally published by Markets. Tap the button above to read the full story on their site.